180 related articles for article (PubMed ID: 31527029)
21. The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.
Steele A; Stacey HJ; de Soir S; Jones JD
Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33138253
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive Use of Phage Sb-1 in Antibiotics Enhances Inhibitory Biofilm Growth Activity versus Rifampin-Resistant
Wang L; Tkhilaishvili T; Trampuz A
Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33138034
[TBL] [Abstract][Full Text] [Related]
23. Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
Abedon ST
Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31614449
[TBL] [Abstract][Full Text] [Related]
24. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
[TBL] [Abstract][Full Text] [Related]
25. Using Bacteriophages as a Trojan Horse to the Killing of Dual-Species Biofilm Formed by
Tkhilaishvili T; Wang L; Perka C; Trampuz A; Gonzalez Moreno M
Front Microbiol; 2020; 11():695. PubMed ID: 32351494
[No Abstract] [Full Text] [Related]
26. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial Efficacy of Two Commercially Available Bacteriophage Formulations, Staphylococcal Bacteriophage and PYO Bacteriophage, Against Methicillin-Resistant
Tkhilaishvili T; Wang L; Tavanti A; Trampuz A; Di Luca M
Front Microbiol; 2020; 11():110. PubMed ID: 32117136
[TBL] [Abstract][Full Text] [Related]
28. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
[TBL] [Abstract][Full Text] [Related]
29. Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity.
Cano EJ; Caflisch KM; Bollyky PL; Van Belleghem JD; Patel R; Fackler J; Brownstein MJ; Horne B; Biswas B; Henry M; Malagon F; Lewallen DG; Suh GA
Clin Infect Dis; 2021 Jul; 73(1):e144-e151. PubMed ID: 32699879
[TBL] [Abstract][Full Text] [Related]
30. Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery.
Rubalskii E; Ruemke S; Salmoukas C; Boyle EC; Warnecke G; Tudorache I; Shrestha M; Schmitto JD; Martens A; Rojas SV; Ziesing S; Bochkareva S; Kuehn C; Haverich A
Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32380707
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus.
Morris JL; Letson HL; Elliott L; Grant AL; Wilkinson M; Hazratwala K; McEwen P
PLoS One; 2019; 14(12):e0226574. PubMed ID: 31877146
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Staphylococcal Bacteriophage Sb-1 as an Adjunctive Agent to Antibiotics Against Rifampin-Resistant
Wang L; Tkhilaishvili T; Trampuz A; Gonzalez Moreno M
Front Microbiol; 2020; 11():602057. PubMed ID: 33262752
[TBL] [Abstract][Full Text] [Related]
33. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant
Bao J; Wu N; Zeng Y; Chen L; Li L; Yang L; Zhang Y; Guo M; Li L; Li J; Tan D; Cheng M; Gu J; Qin J; Liu J; Li S; Pan G; Jin X; Yao B; Guo X; Zhu T; Le S
Emerg Microbes Infect; 2020 Dec; 9(1):771-774. PubMed ID: 32212918
[TBL] [Abstract][Full Text] [Related]
34. Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol.
Onsea J; Soentjens P; Djebara S; Merabishvili M; Depypere M; Spriet I; De Munter P; Debaveye Y; Nijs S; Vanderschot P; Wagemans J; Pirnay JP; Lavigne R; Metsemakers WJ
Viruses; 2019 Sep; 11(10):. PubMed ID: 31548497
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of
Berryhill BA; Huseby DL; McCall IC; Hughes D; Levin BR
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649203
[TBL] [Abstract][Full Text] [Related]
36. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.
Chegini Z; Khoshbayan A; Taati Moghadam M; Farahani I; Jazireian P; Shariati A
Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):45. PubMed ID: 32998720
[TBL] [Abstract][Full Text] [Related]
37.
Olszak T; Danis-Wlodarczyk K; Arabski M; Gula G; Maciejewska B; Wasik S; Lood C; Higgins G; Harvey BJ; Lavigne R; Drulis-Kawa Z
Viruses; 2019 Nov; 11(12):. PubMed ID: 31771160
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological limitations of phage therapy.
Nilsson AS
Ups J Med Sci; 2019 Nov; 124(4):218-227. PubMed ID: 31724901
[TBL] [Abstract][Full Text] [Related]
39. Treatment of chronic left ventricular assist device infection with local application of bacteriophages.
Mulzer J; Trampuz A; Potapov EV
Eur J Cardiothorac Surg; 2020 May; 57(5):1003-1004. PubMed ID: 31651936
[TBL] [Abstract][Full Text] [Related]
40. Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients With Relapsing
Ferry T; Kolenda C; Batailler C; Gustave CA; Lustig S; Malatray M; Fevre C; Josse J; Petitjean C; Chidiac C; Leboucher G; Laurent F
Front Med (Lausanne); 2020; 7():570572. PubMed ID: 33304911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
